That's important, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (second wave). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development practically nobody observed. But it's going to have extensive ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of financial investment chances in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (legacy report prediction). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back maybe considerably prior to going higher - social media. I have actually been covering bitcoin for a long time now. One of the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. However that's not the big question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. toxic tech 5 tech darlings. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of fantastic private companies on the brink of striking the general public markets And I've been dealing with a brand-new way for you to invest even before these companies go public.
This opportunity has been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to schedule your area for free.
Emma Walsh here, managing editor of the Journal. Regular Journal readers know that tech isn't our normal beat (jeff brown genome sequencing stock). And when it concerns tech investing, we leave it to the experts. Luckily, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we understand (jeff bezos). In fact, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential development and developing amazing chances for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. melania trump. But despite what numerous readers might think, this is a trend that's simply getting going. Although the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown 1 biotech company). Losing 2 months of manufacturing and sales actually impacts how lots of 5G devices are offered in the calendar year. When you think about all of that, selling 250 million units is remarkable. More significantly, the hold-ups brought on by the pandemic developed a lots of bottled-up need. Which demand is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be delivered in 2021 - diplomatic relations. And that's not my only 5G prediction When I've talked about 5G in the past, I have actually described its three different phases.
In Stage Two, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase Three, 5G services begin to be used (melania trump). That's when we begin to see applications working on 5G networks. Think about things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase 3 by this summertime. This begins something of a virtuous cycle: Many people do not truly appreciate the technology. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open a suite of extraordinary applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The investment opportunities moving forward will be enormous. Stepping far from 5G, the next essential technology I visualize in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not function properly. CRISPR utilizes a similar concept however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For several years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And during that time, there were truly just 3 business running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing incredible returns. This whole market is successfully a greenfield opportunity.
There's space for lots of business to exist in this area. jeff brown prediction. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is necessary because the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug treatments produced using this technology. This was among those advancements that practically no one noticed. However it's going to have profound implications for curing disease. And, of course, there will be a lot of investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps substantially before going greater. I have actually been covering bitcoin for a long time now. One of the very first research study reports I ever released was on bitcoin - korean actress. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff brown biotech stocks. Mass, Mutual is a 150-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details is up to date as of February 2021, but we might not separately confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like ability to pick winning technology stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an outstanding viewpoint on the market. He's always on the hunt for brand-new chances, and he shares a number of his finest choices in the Near Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively predicted some of the biggest financial events of the previous 20 years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it ideal whenever, however Jeff Brown's accurate predictions have earned him legions of dedicated fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research study provides a number of research study services with a wide range of expertises - exponential tech investor.
The company is also associated with Bonner & Partners, another well-respected research study publisher - exponential growth. On its website, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the very best investment research has actually not been available to individual financiers. It has been normally reserved for financial investment banks, hedge funds, private equity, and high-net-worth customers. brownstone research stock. The objective of Brownstone Research is to make that kind of exclusive research study readily available to any financiers aiming to get an edge in the markets. The goal is basic to provide special and successful investment research study discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you understand even a bit about the market, you understand that he has a track record as a King Midas of sorts. jeff brown predictions for 2021. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In truth, Brown thinks S.A.V. longtime readers. could be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge technologies: expert system and electrical cars and trucks. Musk hopes the mix will assist him develop the first fully-autonomous, self-driving vehicles ever. It's nothing short of the automobile market's Holy Grail. As you know, electric cars and self-driving vehicle stocks have actually been huge this year, but the Wall Street device has actually been huge on buzz without much tangible result. In spite of an extreme boost in competition over the past few years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Vehicle, and it might be the future of transport. Basically, this innovation would enable you to rent out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the automobile and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the profits. It sounds outrageous, but it could be closed than you believe.